Arginetix's Merger

Arginetix raised a round of funding on June 17, 2010. Investors include Corridor Pharmaceuticals.

Arginetix is developing arginase inhibitors for vascular and pulmonary conditions. Merged with Immune Control Inc. to form Corridor Pharmaceuticals.…

Articles about Arginetix's Merger: